Search for: "Research Laboratories v. United States" Results 341 - 360 of 433
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Sep 2011, 8:31 am by Stefanie Levine
” Citing its 2010 decision in Research Corporation Technologies, Inc. v. [read post]
1 Sep 2011, 8:31 am by Stefanie Levine
” Citing its 2010 decision in Research Corporation Technologies, Inc. v. [read post]
16 May 2008, 8:03 am
, 20-21 May: US ACI ‘In-house counsel forum on pharmaceutical antitrust’ – Maryland: (Orange Book Blog), 26-27 May : EU Workshop for mediators in IP disputes – Geneva: (IPR-Helpdesk), 27 May: Oliver Rivers to give short talk on ‘spurious precision’ – London: (IP finance), 28 May / 11June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – New… [read post]
7 Dec 2011, 6:21 pm by Antoinette Konski
Government argued as amicus curiae for the perspective of the United States and the U.S. [read post]
5 Jul 2008, 11:05 am
interview: (IP tango) Events 7 July: PLI briefing webcast ‘Life after Quanta v LGE: What every patent lawyer needs to know’: (PLI), 7-15 July/16-18 July: 2nd Transatlantic IP summer academy, modules one and two – Alicante/Milan: (IPKat), 9 July 2008: ALI & ABA webcast ‘Quanta v LG: What you should know’: (Patent Docs), 11 July: CIPA moot to improve participants’ understanding of procedures of EPO Technical… [read post]
9 Sep 2013, 10:03 pm by Daniel B. Cohen
” Most of the surface waters of the United States will fail the generic E. coli standard either persistently, predictably during certain times of the year or intermittently. [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
16 May 2023, 1:41 pm by Michael Lowe
(B) The drug or other substance has a currently accepted medical use in treatment in the United States. [read post]
President Biden will soon sign into law the Inflation Reduction Act (IRA), which provides $750 billion in funding and major federal policy changes impacting the U.S. energy, environment, healthcare and tax sectors. [read post]
4 Oct 2011, 12:13 pm by David Kravets
One of the Obama administration’s main arguments in support of warrantless GPS tracking is the high court’s 1983 decision in United States v. [read post]
12 Jan 2010, 5:00 am by Beck, et al.
Abbot Laboratories, No. 08 Civ. 7480, 2009 WL 2231701 (S.D.N.Y. [read post]
10 Dec 2010, 4:32 pm
” Standardized Field Sobriety Tests: In February 1975, the first major scientific study within the United States was conducted to attempt to identify the most reliable FSTs and study their relationship to intoxication and driving impairment. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
20 Apr 2019, 10:37 am by Bill Marler
To improve surveillance, the Council of State and Territorial Epidemiologists has recommended that all L. monocytogenesisolates be forwarded to state public health laboratories for subtyping through the National Molecular Subtyping Network for Foodborne Disease Surveillance (PulseNet). [read post]
22 Feb 2017, 9:26 pm by Bill Marler
To improve surveillance, the Council of State and Territorial Epidemiologists has recommended that all L. monocytogenes isolates be forwarded to state public health laboratories for subtyping through the National Molecular Subtyping Network for Foodborne Disease Surveillance (PulseNet). [read post]